Comparison of Exsufflation Versus Drainage in Primary Spontaneous Pneumothorax

NCT ID: NCT01008228

Last Updated: 2020-02-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

402 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Management of primary spontaneous pneumothorax (PSP) remains unclear. Primary therapeutic goals for PSP include removal of air from the pleural space an prevention of recurrences. The absence of generally accepted and methodologically sound recommendations may account for the extensive variation in practice for air evacuation techniques. Air evacuation may be achieved by simple aspiration (exsufflation) or conventional chest tube drainage. Chest tube thoracotomy remains the most popular technique.Aspiration is a more simple technique, that allows possibility of ambulatory management. The purpose of the present study is to compare simple aspiration performed with a specific thoracentesis device, versus conventional chest tube drainage. Comparison will be performed on immediate efficacity of resolution of the pneumothorax.The hypothesis is that simple aspiration performed with a specific device is not inferior to chest tube drainage for management of a first episode of large size primary spontaneous pneumothorax. A second goal is to measure the efficacy at one week, and the recidive at one year. The trial is randomized, controlled and will include 200 patients for each group. The patients will be enrolled in 29 hospitals in France. Emergency department, thoracic surgery and pulmonary departments of each hospital were primarily contacted for agreement to participate to the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumothorax

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

tube thoracic drainage

drainage performed with tube drainage CH 16 or ch 20

Group Type ACTIVE_COMPARATOR

thoracic tube drainage

Intervention Type PROCEDURE

thoracic tube drainage will be performed with a tube Ch 16 or ch 20

exsufflation

exsufflation with a specific thoracentesis system

Group Type EXPERIMENTAL

exsufflation

Intervention Type PROCEDURE

exsufflation will be performed with a specific thoracentesis system after introducing the device into chest pneumothorax, aspiration will be performed during 30 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

exsufflation

exsufflation will be performed with a specific thoracentesis system after introducing the device into chest pneumothorax, aspiration will be performed during 30 minutes

Intervention Type PROCEDURE

thoracic tube drainage

thoracic tube drainage will be performed with a tube Ch 16 or ch 20

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Turkel Kit Monod Trocar Chest Tube

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients aged more than 18 years and less than 50 years
* first episode of pneumothorax
* primary pneumothorax (absence of known pulmonary disease)
* large size of pneumothorax : presence of a visible rim of air between the lund margin and the chest wall, from the apex to pulmonary base

Exclusion Criteria

* impossibility to obtain patient consent for psychiatric disease
* patients under justice control
* âgé less than 18 years, or more than 50 years
* impossibility of medical follow de for geographic, social or psychic reasons
* pregnant women
* pneumothorax with acute respiratory insufficiency or bad tolerated
* recidive of pneumothorax
* traumatic pneumothorax
* pneumothorax with pleural effusion
* bilatéral pneumothorax
* pneumothorax with pulmonary disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role collaborator

Belfort Hospital

OTHER

Sponsor Role collaborator

Central Hospital, Nancy, France

OTHER

Sponsor Role collaborator

Norman Bethune Medical Hospital

OTHER

Sponsor Role collaborator

St Philibert Hospital, Lomme

UNKNOWN

Sponsor Role collaborator

Hospital of Montfermeil

UNKNOWN

Sponsor Role collaborator

University Hospital, Brest

OTHER

Sponsor Role collaborator

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role collaborator

Nantes University Hospital

OTHER

Sponsor Role collaborator

Association Hospitalière Nord Artois Cliniques

OTHER

Sponsor Role collaborator

Poitiers University Hospital

OTHER

Sponsor Role collaborator

University Hospital, Tours

OTHER

Sponsor Role collaborator

CHU de Reims

OTHER

Sponsor Role collaborator

Centre hospitalier de Perpignan

OTHER

Sponsor Role collaborator

Hospices Civils de Lyon

OTHER

Sponsor Role collaborator

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role collaborator

Hospital of Roubaix

UNKNOWN

Sponsor Role collaborator

Hospital of Boulogne/mer

UNKNOWN

Sponsor Role collaborator

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role collaborator

University Hospital, Rouen

OTHER

Sponsor Role collaborator

University Hospital, Angers

OTHER_GOV

Sponsor Role collaborator

Centre Hospitalier le Mans

OTHER

Sponsor Role collaborator

Centre Hospitalier Universitaire de Nīmes

OTHER

Sponsor Role collaborator

University Hospital, Grenoble

OTHER

Sponsor Role collaborator

Hospital of Mulhouse

UNKNOWN

Sponsor Role collaborator

Hospital of Valence

UNKNOWN

Sponsor Role collaborator

Centre Hospitalier Universitaire de Besancon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

DESMETTRE

Dr Thibaut Desmettre, MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thibaut TJ Desmettre

Role: PRINCIPAL_INVESTIGATOR

Hospital University of Besancon

Thibaut DESMETTRE, MD

Role: PRINCIPAL_INVESTIGATOR

CHU Besançon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Intercommunal de la Haute Saône

Vesoul, Franche Comté, France

Site Status

CHU Angers

Angers, , France

Site Status

Hôpital Henri Mondor

Aurillac, , France

Site Status

Centre Hospitalier

Belfort, , France

Site Status

CHU Besancon

Besançon, , France

Site Status

CH Bethune

Béthune, , France

Site Status

CH Boulogne sur Mer

Boulogne-sur-Mer, , France

Site Status

CHU Clermont Ferrand

Clermont-Ferrand, , France

Site Status

CHU Dijon

Dijon, , France

Site Status

CHU Grenoble

Grenoble, , France

Site Status

Clinique de HENIN BEAUMONT

Hénin-Beaumont, , France

Site Status

CH Lomme

Lomme, , France

Site Status

CHU Marseille

Marseille, , France

Site Status

Chi Le Raincy/Montfermeil

Montfermeil, , France

Site Status

CH Mulhouse

Mulhouse, , France

Site Status

CHU Nimes

Nîmes, , France

Site Status

CH Perpignan

Perpignan, , France

Site Status

CHU Poitiers

Poitiers, , France

Site Status

CHU Reims

Reims, , France

Site Status

CHR Roubaix

Roubaix, , France

Site Status

CH Rouen

Rouen, , France

Site Status

CHU Saint Etienne

Saint-Etienne, , France

Site Status

CHU Toulouse

Toulouse, , France

Site Status

CHU Tours

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Desmettre T, Meurice JC, Kepka S, Dalphin JC. [Treatment of first spontaneous pneumothorax: drainage or exsufflation?]. Rev Mal Respir. 2011 Jan;28(1):5-8. doi: 10.1016/j.rmr.2010.10.028. Epub 2011 Jan 12. No abstract available. French.

Reference Type BACKGROUND
PMID: 21277468 (View on PubMed)

Desmettre T, Meurice JC, Mauny F, Woronoff MC, Tiffet O, Schmidt J, Ferretti G, Dalphin JC. [Comparison of simple aspiration versus standard drainage in the treatment of large primary spontaneous pneumothorax]. Rev Mal Respir. 2011 Mar;28(3):336-43. doi: 10.1016/j.rmr.2010.10.030. Epub 2011 Mar 10. French.

Reference Type BACKGROUND
PMID: 21482337 (View on PubMed)

Desmettre T, Meurice JC, Tapponnier R, Pretalli JB, Dalphin JC. [The EXPRED study: where are we?]. Rev Mal Respir. 2013 Jan;30(1):18-21. doi: 10.1016/j.rmr.2012.09.019. Epub 2012 Nov 13. No abstract available. French.

Reference Type BACKGROUND
PMID: 23318185 (View on PubMed)

Marx T, Joly LM, Parmentier AL, Pretalli JB, Puyraveau M, Meurice JC, Schmidt J, Tiffet O, Ferretti G, Lauque D, Honnart D, Al Freijat F, Dubart AE, Grandpierre RG, Viallon A, Perdu D, Roy PM, El Cadi T, Bronet N, Duncan G, Cardot G, Lestavel P, Mauny F, Desmettre T. Simple Aspiration versus Drainage for Complete Pneumothorax: A Randomized Noninferiority Trial. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1475-1485. doi: 10.1164/rccm.202110-2409OC.

Reference Type DERIVED
PMID: 36693146 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R/2009/38

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.